TLR4 and viral pneumonia: The results of this study showed that LHQW treatment reduced the viral loads and adjusted inflammatory factors in the lungs, alleviated lung injury, and inhibited the activation of the TLR4/NF-κB signalling pathway in viral pneumonia mice (Figures 1C, 8B).